General Information of Drug (ID: DM8KRA3)

Drug Name
EDP-514
Indication
Disease Entry ICD 11 Status REF
Chronic HBV infection 1E51.0Z Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
DDY51F

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Hepatitis B virus Capsid protein (HBV C) TTM42UJ CAPSD_HBVD3 Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04470388) A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Enanta Pharmaceuticals.